A detailed history of Walleye Trading LLC transactions in Amgen Inc stock. As of the latest transaction made, Walleye Trading LLC holds 200 shares of AMGN stock, worth $51,855. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 258,300 99.92%
Holding current value
$51,855
Previous $80.7 Million 99.92%
% of portfolio
0.0%
Previous 0.2%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $309,380 - $337,380
-1,000 Reduced 83.33%
200 $64,000
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $315,300 - $383,172
1,200 New
1,200 $374,000
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $376,043 - $444,664
1,755 New
1,755 $389,000
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $10.1 Million - $12.8 Million
44,002 Added 83.56%
96,663 $25.4 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $1.16 Million - $1.31 Million
5,189 Added 10.93%
52,661 $11.9 Million
Q2 2022

Aug 08, 2022

BUY
$230.71 - $256.74 $9.35 Million - $10.4 Million
40,535 Added 584.33%
47,472 $11.6 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $1.18 Million - $1.36 Million
5,955 Added 606.42%
6,937 $1.56 Million
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $2.45 Million - $2.92 Million
-11,336 Reduced 92.03%
982 $226,000
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $3.8 Million - $4.45 Million
-22,451 Reduced 64.57%
12,318 $2.1 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $3.54 Million - $3.96 Million
20,998 Added 152.48%
34,769 $6.05 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $1.09 Million - $1.24 Million
6,486 Added 89.03%
13,771 $2.57 Million
Q2 2017

Aug 14, 2017

BUY
N/A
7,285
7,285 $1.26 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $139B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.